RELEASE GATE
FDA U.S. Agent Coordination

WHAT WE COORDINATE
A focused route through FDA U.S. Agent Coordination.
- 01
Identify product and intended use
Define the decision, facts, and owner.
- 02
Map agencies, standards, and states
Confirm the evidence and review points.
- 03
Assemble technical and commercial evidence
Coordinate the approved route and dependencies.
- 04
Coordinate qualified review and records
Hand the result to the next owner.

READY TO MOVE?
Move FDA U.S. Agent Coordination into an owned workstream.
FAQ
Questions before a product is released for U.S. sale.
What decision should FDA U.S. Agent Coordination resolve first?
Start with the narrow business decision that must be made now. On this page, that means deciding how to coordinate the U.S. communication role required for a covered foreign FDA-regulated establishment without presenting the coordinator as FDA.
What is included in a FDA U.S. Agent Coordination engagement?
Only the workstreams, deliverables, evidence requests, review points, acceptance criteria, and handoffs in the signed scope are included. This page is an educational description—not a proposal, fixed price, guaranteed timeline, or promise of approval or commercial results.
Which parts of FDA U.S. Agent Coordination require independent professionals?
Legal, tax, immigration, banking, customs, insurance, securities, employment, FDA, and other regulated determinations are made or reviewed by appropriately qualified independent professionals. B2B Sales Pilot coordinates the facts and handoffs but does not substitute for those roles.